Two walls, not one

A mitochondrion has two membranes. Think of it as a balloon inside a balloon.

The outer membrane is smooth and wraps the whole thing. The inner membrane is folded over and over on itself, like a crumpled sheet stuffed inside a bag. Those folds are called cristae.

The folds matter because the inner membrane is where energy is made. More folds means more surface, and more surface means more room for the machinery that turns food and oxygen into ATP, the cell's energy currency.

The unusual fat that holds the folds

Membranes are made of fats called lipids. One of them is found almost only in mitochondria, and it is called cardiolipin.

The paper explains that in healthy cells, cardiolipin sits mainly in the inner membrane, where it helps keep the cristae stable. You can think of it as part of the scaffolding that holds the folds in shape.

Cardiolipin is also where SS-31 comes in. SS-31 is known to associate with cardiolipin and to help stabilise cristae structure. That is one of the main explanations for how it protects mitochondria: it helps keep the inner wall properly folded and working.

What happens to cardiolipin during cell death

Here is where it gets interesting, and where the paper's hypothesis comes from.

During apoptosis, cardiolipin does not stay where it belongs. It gets moved from the inner membrane to the outer membrane. That has two effects.

First, the cristae lose their scaffolding and start to fall apart. As they do, cytochrome c, which normally sits tucked inside those folds, is freed into the space between the two membranes, ready to escape.

Second, cardiolipin on the outer membrane changes the shape and properties of that surface. And BAX, the trigger protein from Part 2, tends to gather at spots where cardiolipin is dense. Some researchers think cardiolipin on the outer membrane acts like a landing pad for BAX.

DRP1, the other player

There is one more protein in this story: DRP1. It is best known for helping mitochondria split apart, a process called fission.

But the paper explains that DRP1 is also involved in apoptosis. It appears to help regulate the breakdown of cristae and the movement of cardiolipin to the outer membrane. That would make it part of building the landing pad for BAX.

What happens when DRP1 is not working properly? Earlier studies from the same lab and others found:

  • BAX can still start gathering on mitochondria.
  • But total BAX recruitment only reaches about 75% of normal.
  • Release of cytochrome c is impaired.
  • The usual fragmentation of mitochondria at the end of the process is much reduced.

The hypothesis

Now put those pieces together, the way the Wisconsin team did.

  • SS-31 binds cardiolipin and stabilises the cristae.
  • Cardiolipin moving to the outer membrane is part of what makes BAX gather and cytochrome c escape.
  • DRP1 helps make that cardiolipin move.
  • When DRP1 is broken, BAX gathers less, cytochrome c release is impaired and mitochondria fragment less.

So the team asked a sharp question. If SS-31 holds cardiolipin in place in the inner membrane, does it have the same effect as broken DRP1?

If so, cells treated with SS-31 should show:

  1. Less BAX gathering on mitochondria
  2. Less cytochrome c escaping
  3. Less mitochondrial fragmentation

That is a clean, testable prediction. And it fit with the earlier reports, including the brain bleed study, that SS-31 reduced BAX on mitochondria.

Why I like this setup

What makes this study worth reading is that the hypothesis was reasonable. It was built from known biology, connected SS-31's best-understood action, binding cardiolipin, to an important outcome, BAX recruitment, through a plausible chain.

When a reasonable hypothesis is tested carefully and does not fully hold up, you learn something real. You learn that the chain breaks somewhere. That is far more useful than a vague claim that a compound "supports mitochondrial health" with nothing specific enough to test.

What comes next

To test the prediction, the team needed to watch all three things, BAX, cytochrome c and mitochondrial shape, at the same time, in the same living cells, as they went through apoptosis.

That is a genuinely difficult experiment. In the next part, we look at how they did it.

This series discusses a peer-reviewed laboratory study in cultured cells. The results have not been shown in people. Nothing here is medical advice, and SS-31 is discussed for research purposes only.